2367P A randomized phase II study of atezolizumab (atezo) plus recombinant human IL-7 (CYT107) vs. atezo alone in patients with locally advanced or metastatic urothelial carcinoma (mUC)
Annals of Oncology（2023）
关键词
metastatic urothelial carcinoma,urothelial carcinoma,atezolizumab,atezolizumab,cyt107
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要